In the last years, the incidence of Candida infections in liver transplant recipients has increased with still higher morbidity and mortality. Anidulafungin, a new echinocandin that does not interfere with cytochrome p450, shows no need for dosage adjustment based upon renal or hepatic function or weight.

Sganga, G., Pepe, G., Cozza, V., Nure, E., Lirosi, M. C., Frongillo, F., Grossi, U., Bianco, G., Agnes, S., Anidulafungin--a new therapeutic option for Candida infections in liver transplantation, <<TRANSPLANTATION PROCEEDINGS>>, 2012; 44 (7): 1982-1985. [doi:10.1016/j.transproceed.2012.06.029] [http://hdl.handle.net/10807/40542]

Anidulafungin--a new therapeutic option for Candida infections in liver transplantation

Sganga, Gabriele;Pepe, Gilda;Nure, Erida;Lirosi, Maria Carmen;Frongillo, Francesco;Grossi, Ugo;Bianco, Giuseppe;Agnes, Salvatore
2012

Abstract

In the last years, the incidence of Candida infections in liver transplant recipients has increased with still higher morbidity and mortality. Anidulafungin, a new echinocandin that does not interfere with cytochrome p450, shows no need for dosage adjustment based upon renal or hepatic function or weight.
Inglese
Sganga, G., Pepe, G., Cozza, V., Nure, E., Lirosi, M. C., Frongillo, F., Grossi, U., Bianco, G., Agnes, S., Anidulafungin--a new therapeutic option for Candida infections in liver transplantation, <>, 2012; 44 (7): 1982-1985. [doi:10.1016/j.transproceed.2012.06.029] [http://hdl.handle.net/10807/40542]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/40542
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact